SABBY MANAGEMENT, LLC — 13F Holdings & Portfolio
CIK 1535610 · latest 13F-HR filed 2026-05-15
SABBY MANAGEMENT, LLC manages $45.1M in 13F-reported U.S. long-equity assets across 28 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are XCNY (64.50%), IFXAF (16.51%), SPY (3.94%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 13 new positions, exited 16, added to 1, and trimmed 8.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$45.1M
Long-equity book
28
Distinct positions
2026-03-31
Filed 2026-05-15
+13 / −16 / ↑1 / ↓8
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Trims
- LYRA THERAPEUTICS INC-$488.4K -90.5%
- TEMPEST THERAPEUTICS INC-$483.3K -94.3%
- BIODEXA PHARMACEUTICALS PLC-$273.7K -63.2%
- POP CULTURE GROUP CO LTD-$200.7K -49.9%
- SENESTECH INC-$92.2K -20.5%
New Positions
- ALPHATON CAPITAL CORP$654.8K
- BRIACELL THERAPEUTICS CORP$392.1K
- BIG TREE CLOUD HLDGS LTD$337.1K
- BRIACELL THERAPEUTICS CORP$309.7K
- TOKEN CAT LTD$241.7K
Exited Positions
- BIG TREE CLOUD HLDGS LTD$1.6M
- EMPERY DIGITAL INC$1.6M
- BLINK CHARGING CO$1.4M
- BITCOIN DEPOT INC$1.3M
- ABIVAX SA$947.5K
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF Put | XCNY | 78462F953 | $29.1M | 64.50% | 447 | SH |
| 2 | ISHARES TR Put | IFXAF | 464287955 | $7.4M | 16.51% | 300 | SH |
| 3 | SPDR S&P 500 ETF | SPY | 78462F103 | $1.8M | 3.94% | 2,734 | SH |
| 4 | GEVO INC Put | GEVO | 374396956 | $1.4M | 3.18% | 5,252 | SH |
| 5 | ABIVAX SA Call | AAVXF | 00370M903 | $857.4K | 1.90% | 77 | SH |
| 6 | ALPHATON CAPITAL CORP | ALP | G7185A136 | $654.8K | 1.45% | 2,072,103 | SH |
| 7 | BRIACELL THERAPEUTICS CORP | BCTXL | 107930125 | $392.1K | 0.87% | 380,686 | SH |
| 8 | SENESTECH INC | SNES | 81720R604 | $358.4K | 0.80% | 218,533 | SH |
| 9 | BIG TREE CLOUD HLDGS LTD | DSY | G1263B132 | $337.1K | 0.75% | 137,611 | SH |
| 10 | ZEVRA THERAPEUTICS INC Put | ZVRA | 488445956 | $316.9K | 0.70% | 340 | SH |
| 11 | BRIACELL THERAPEUTICS CORP | BCTX | 107930307 | $309.7K | 0.69% | 73,915 | SH |
| 12 | SIDUS SPACE INC Put | SIDU | 826165951 | $243.4K | 0.54% | 1,049 | SH |
| 13 | TOKEN CAT LTD | TC | 89856T401 | $241.7K | 0.54% | 23,239 | SH |
| 14 | POP CULTURE GROUP CO LTD | CPOP | G71700119 | $201.1K | 0.45% | 664,449 | SH |
| 15 | MOLECULIN BIOTECH INC | MBRX | 60855D408 | $171.8K | 0.38% | 75,021 | SH |
| 16 | BIODEXA PHARMACEUTICALS PLC | BDRX | 59564R880 | $159.1K | 0.35% | 257,472 | SH |
| 17 | ARCADIA BIOSCIENCES INC | RKDA | 039014303 | $158.1K | 0.35% | 114,554 | SH |
| 18 | TRX GOLD CORP | TRX | 87283P109 | $150.0K | 0.33% | 100,000 | SH |
| 19 | INMED PHARMACEUTICALS INC | INM | 457637700 | $142.0K | 0.32% | 220,260 | SH |
| 20 | CAN FITE BIOFARMA LTD | CANF | 13471N409 | $131.9K | 0.29% | 42,559 | SH |
| 21 | CHINA SXT PHARMACEUTICALS INC | SXTC | G2161P165 | $131.3K | 0.29% | 78,170 | SH |
| 22 | REVELATION BIOSCIENCES INC | REVB | 76135L804 | $119.3K | 0.26% | 99,432 | SH |
| 23 | CALIDI BIOTHERAPEUTICS INC | CLDI | 320703408 | $103.9K | 0.23% | 434,903 | SH |
| 24 | BLUEJAY DIAGNOSTICS INC | BJDX | 095633608 | $52.9K | 0.12% | 28,726 | SH |
| 25 | LYRA THERAPEUTICS INC | LYRA | 55234L204 | $51.1K | 0.11% | 104,059 | SH |
| 26 | TEMPEST THERAPEUTICS INC | TPST | 87978U207 | $29.3K | 0.06% | 17,856 | SH |
| 27 | BRIACELL THERAPEUTICS CORP | BCTXZ | 107930117 | $28.9K | 0.06% | 206,753 | SH |
| 28 | BNB PLUS CORP | BNBX | 03815U607 | $8.7K | 0.02% | 13,541 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | $45.1M | 28 | 0001104659-26-061764 |
| 2025-12-31 | 2026-02-17 | $69.5M | 33 | 0001104659-26-015753 |
| 2025-09-30 | 2025-11-14 | $86.4M | 39 | 0001104659-25-111938 |